chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for the Covid virus on 02Feb; tested positive for the Covid virus on February 2nd.; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 3 patients. This is 2nd of 3 reports. A 77-year-old patient of unspecified gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Pharmacy technician, calling on behalf of three patients who tested positive after receiving the first dose of the Covid vaccine, asked when they can get the second dose of the Covid vaccine. They received their first dose on 16Jan2021 and tested positive for the Covid virus on 02Feb2021. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021138460 same drug/event, different patients
My fingers started getting stiff in both hands. the right hand was worse and my thumb began clicking when I flexed it. My thumb would snap into position and then snap to the open position. Dr. called it trigger finger and I received a cortisone shot for my thumb in my right hand, on July 14, 2021 and another on Aug 4, 2021
Got it so bad; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 weeks after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Got it so bad). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 01-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that the Shingles was awful. The reporter thought that if she would had not received the shingles vaccine she would not gotten the shingles. The follow-up could not be possible as no contact details were available.
Nausea, body aches, fever (100.1 max), headache, extreme fatigue. Fever one day, body aches, extreme fatigue and headaches 2 days, normal fatigue and nausea about a week.
Patient became diaphoretic, dizzy after receiving vaccine. Patient requested to lay on floor, BP checked 95/41. Patient given fluids, peanut butter, BP returned to baseline shortly after. Patient endorses previous history of vagal response to blood draws, finger pricks etc.
sore right sjoulder injection site arm; after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right sjoulder injection site arm) and THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN and INSULIN ASPART (NOVOLOG) for Diabetes, INSULIN for Diabetes mellitus.   On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, the patient experienced VACCINATION SITE PAIN (sore right sjoulder injection site arm). In September 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now). At the time of the report, VACCINATION SITE PAIN (sore right sjoulder injection site arm) and THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Blood glucose: 160 (Low) went down to 160. In September 2021, Blood glucose: 160 (Low) went down to 160. On an unknown date, Blood glucose: running between 250 to 300 (High) running between 250 to 300.         No treatment medications were reported Patient struggled to manage Type2 diabetes, walking as much as the patient could, rarely more than half a mile, and eating low sugar snacks and taking insulin shots, the FlexTouch (insulin degludec injection) at 35 units once a day, and the Novolog Flexpen (fast acting) at 20 units 3/day.  Patient feels pretty sure that it was not coincidental as there were no other changes in his lifestyle, other than the vaccine. On the previous day, the patient walked a full mile for the first time in a long time and felt confident enough. Patient believed that the vaccine worked miraculously in controlling the diabetes.   This case was linked to MOD-2021-321312 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: New concomitant medications added, added information in inarrative supplement.
Information has been received from a physician concerning an 11 year old female patient who was vaccinated on an unspecified date with her second dose of with GARDASIL. The physician stated that her patient had an "acute pain, chest pain and pain in her body" immediately after the vaccine was given. It was reported that the vaccine was given by the patient's pediatrician (name unspecified) but the patient is now seeing her family physician (the reporter). On 23-SEP-2009 the patient was seeing by her family physician that placed the patient on anti-inflammatory medication (name unspecified) and was sent to home). The reporter informed that on 16-OCT-2009 the patient came back to the office with "body aches, headaches and shortness of breath". A blood test was done at this time and the patient continued anti-inflammatory medication. Also was reported that on 19-OCT-2009 the patient had the same complaints including malaise and the blood work was all found to be normal. The reporter mentioned that the patient was placed on prednisone and was sent to home. No adverse events were reported after the first dose of GARDASIL was given. The patient sought medical attention in office visit. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Began to have a slight tingling feeling in my bottom lip a few hours after vaccine.   Next day, the tingling continued and felt more burning sensation but never severe.   However, did contact my primary care provider and they suggested that I take Benadryl to help it.   I took it for several days and the tingling/burning feeling stopped completely after about 10 days.      I did not have any swelling of lips or tongue but just the tingling/burning sensation.
Patient received a Pfizer Monovalent booster instead of a bivalent booster. Patient's parent informed of the vaccine administration error.  Mom advised  patient  may receive a bivalent booster at least two months after the dose given in error.
3 MINUTES AFTER VACCINE, LEFT ARM STARTED ITCHING AND RASH. HAS SINCE RESOLVED, NO SOB OR RESPIRATORY DISCOMFORT.  PATIENT ALERT AND ORIENTED.  ENCOURAGED TO CALL OR VISIT HER PCP AS NEEDED.
The child receiving the vaccine wiggled away and did not receive the full dose; This spontaneous report has been received from a nurse practitioner referring a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.   On an unknown date, the patient started therapy with measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, administered for prophylaxis (strength, dose, frequency, lot number, expiration date and route of administration were not provided).   On 22-AUG-2022 the patient did not receive the full dose (accidental underdose).   This is one of two cases from the same reporter.; Sender's Comments:  US-009507513-2208USA008733:
4"x6" area: red, swollen, hard, hot, itchy.  Treated with ice packs. Itchy feeling has continued  for  3 days over body: scalp, back, feet.
Information has been received from an office manager concerning a female patient who during the time period of 11-OCT-2006 through 17-OCT-2006 was vaccinated with a dose of Pneumovax 23 (lot #s 6514370/899F, 651404/0352F, 651404/0619F and 651328/1046P), intramuscularly. Subsequently, "within the past 7 to 10 days" the patient experienced swelling and pain in the injected arm. The patient was treated with an unspecified cream for the pain. The physician requested a lot check. The records of testing prior to release of the lots in question have been rechecked and found to be satisfactory. The lot met the agency requirements and was released. Additional information has been requested.
About 10 minutes after vaccination patient said that she started to feel a tingle/scratch in her throat and had a little shortness of breath. She was not wheezing or gasping for air but had to stop a little as she was talking to breathe in. After 3-4 minutes she stated that she felt the same but it was not going away. EMTs were called Epi-Pen was ready for use if the patient started to suddenly feel worse.  EMTs arrived in about 6-7 minutes the patient added that she was beginning to feel a tingling around her lips. EMTs told her to stick her tongue out and checked airway and took her into the ambulance to get checked out. Patient has no drug allergies, has not had reactions to vaccines in the past, the only allergy she reported was pollen and topical cocoa butter.
Patient presented to clinic for Varicella vaccine due to low titer.  She  was given Zoster.   Vaccine request sheet was filled out, and signed by patient and provider, but error was not caught until after clinic closed.  Patient has been notified.  No symptoms  have been reported at this time.
RN administered MMR vaccine in non preferred injection site.  RN administered vaccine SQ abdomen.  Preferred immunization site for MMR is upper outer arm SQ. Patient called with local reaction-  rash "size of grapefruit", hard lump under skin "size of half dollar", itching, pain, redness, and swelling.
Onset generalized petechial rash several hours after influenza vaccine. Area without other symptoms. Mild peripheral eosinophilia 10/9, decreasing 10/11. No reporting of joint symptoms. No seizures. Child does have multiple medication allergies.
A more heavier and painful menstrual cycle that was extended for approximately 14+ days (which has never happened before). Be advised, in speaking with others, additional reports are surfacing that more and more woman are experiencing similar and additional menstrual cycle problems, including missed periods, after receiving the Covid vaccination.  Pre-menopausal woman have a right to know this is a potential side effect to not only educate but eliminate fear and conspiracy theories, which would deter and hinder other woman (especially those of child bearing years) to not get vaccinated.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a male of unknown age. Neither medical history nor concomitant medications were reported. On 10-Feb-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause of the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: product complaint investigation results.
Told patient to wait 15 minutes in waiting area after receiving vaccine.  About 5-10 minutes after receiving vaccine, patient started to become pale and reported dizziness.  Patient's parents were present with him in waiting area.  Witnessed patient collapse in chair and father moved patient from chair to the floor to avoid head injury.  I had technician call for an ambulance right away.  Father of patient roused patient since he appeared to lose consiousness momentarily.  After rousing him several times,  he started to make jerking movements similar to a seizure, but eventually regained consiousness within a minute. This all happened over the course of about 1-2 minutes  Patient sat in chair until ambulance arrived at the scene.  Patient was cleared to go home.  Patients parents report that this sort of thing has happened before with other vaccines, which was not reported on the consent form.  Father said it is a "vagal nerve" thing in his head and thinks it was more likely to be related to patients nerves rather than the vaccine itself.
Muscle soreness, shivering, no fever, kind of flu-like symptoms, no nausea. Going on 24 hours now, not ended yet.
Information has been received from a health professional and a physician's office concerning an approximately 12 month old white female with a history of iron deficiency anemia, allergies (unspecified) and a hospital admission for Rotavirus infection (in 1995) who in 1995 was vaccinated with MMR II (lot 615715/0611B). Concomitant therapy included cefixime (Suprax). The nurse reported that there was a "possible" problem with the MMR II. After vaccination, the pt developed a rash and a fever. It was noted that "the Suprax may have possibly caused the rash and fever, the doctors were not sure." It was also reported that the pt received another dose of MMR II in 1999 and did not have any adverse events post this vaccination. The pt had a similar experience after vaccination with pneumococcal vaccine 23 polyvalent  (WAES0201USA00920). Additional info has been requested.
#0 minutes following the vaccine dose, the patient was brought back to the clinic .  He was unable to speak intelligibly but was alert. His family reported that he had just been released from the hospital for "TIAs".
Soreness; tenderness; redness; hard lump; Lymph nodes swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), TENDERNESS (tenderness), ERYTHEMA (redness), MASS (hard lump) and LYMPHADENOPATHY (Lymph nodes swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (Soreness), TENDERNESS (tenderness), ERYTHEMA (redness), MASS (hard lump) and LYMPHADENOPATHY (Lymph nodes swollen). At the time of the report, PAIN (Soreness), TENDERNESS (tenderness), ERYTHEMA (redness), MASS (hard lump) and LYMPHADENOPATHY (Lymph nodes swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Patient was administered a Td vaccine while in the office. Patient jerked and the needle came out and some of the liquid squirted on the patients arm. Unknown how much vaccine he got.
Abdominal discomfort, nausea, diarrhea for 36 hrs post 2nd inject; started 7 days p/the inject; no vomiting, no local rxn; feels better as of 21JUN91; no problems p/1st dose on 12JUN91;
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 30-NOV-2015, the patient was inoculated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2015, the patient was treated by at a medical center for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 09/27/2021. PATIENT WAS FULLY VACCINATED ON 02/20/2021.
t102-105.1 R cool bath 1 1/2 days high pitched crying APAP, Advil wrapped in cool towel
Severe tiredness, every part of me ached, fever and some nausea.  These symptoms got worse throughout day.   Slept probably 20 hours of 24
Mom called on 1/4/02 to report a small knot and a rash on the right leg at injection site. Mom took child to ER and MD said "nothing was wrong".
Patient received Pfizer COVID vaccine on 3/27/21 and 4/22/21. On 1/18/22, patient tested positive for COVID. On 1/20/22, patient admitted to our inpatient facility med/surg unit with SIRS/sepsis, COVID-19 pneumonia, acute hypoxic respiratory failure, secondary to COVID-19 pneumonia, acute metabolic encephalopathy related to SIRS/sepsis, AML with severe leukocytosis and blasts, and severe anemia/thrombocytopenia related to AML. As of today (1/22/22), patient is still admitted in our med/surg unit.
Information has been received from a physician concerning a female (age unknown) with unknown medical history who "may have had psychological issues", was vaccinated "last year" in 2007 (route unknown) with a dose of Gardasil (Lot # unknown).  The physician reports that last year a patient in one of the Urgent cares had an anaphylactic reaction after receiving the vaccine.  The patient was told to go the ER.  Unspecified medical attention was sought.  Outcome unknown.  No product quality complaint was involved.  Additional information has been requested.
Pt recvd MMR/DPT/OPV/PPD vax on 8MAY91 & immed p/vax devel redness, swelling & inc temp @ inject site; pt was kept for observation & released upon recovery;
9 month old patient received Pfizer COVID vaccine (maroon cap) for 6mo-4yo on 9/8/22 as a 2nd dose. However, patient received Moderna COVID vaccine (pink label) for 6mo-5yo as a 1st dose on 8/9/22. So patient should've received a Moderna COVID vaccine for a 2nd dose on 9/8/22. This is an administration error, but no adverse event to the pt occurred.
3-4hr p/vax pt exp chills w/sweating;general malaise & body ache for 2 days;did not require hosp; vaccine insert recommends discontinuance of anthrax series w/chills or fever p/vax;
Adult dose of Hepatitis A was administered to a 16 year old female. Age of patient at time of event: 16 years 5 months 20 days.
Soreness at the injection site after first dose of Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Soreness at the injection site after first dose of Shingrix). The outcome of the injection site pain was resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.     It was unknown if the company considered the injection site pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 10-MAY-2023 The patient received 1st dose of Shingrix and experienced soreness at the injection site. The reporter did not consented to follow up.
Patient states she felt slightly dizzy after getting up to leave facility upon completing her 30 minute post vaccination monitoring.  Vitals taken after patient was seated in a chair.  BP 130/70 P 84 O2 sat 98%.  Patient requested to hydrate, rest and remain in post vaccination monitoring an additional 30 minutes until 1000.  Discharged at 1000 and instructed her to call 911 with any emergent issues after departure from facility- verbalized understanding and form signed.
Pt receiving one dose of varicella virus vaccine live 2.5 weeks post exposure. Approximately 3 days post vax the pt developed approximately half dozen pox. It was noted that the pt was afebrile. The pts sister had a similar experience following exposure to varicella virus vaccine live. Follow up was received which indicated the pt recovered after a few days.
Within a few hours of the injection (day 1), I developed pain when moving the injected arm, as well as a throbbing, shooting pain even when motionless. The shooting went through my arm towards the armpit. The following day (day 2), I developed a fever that topped out at 103 and severe swelling in the armpit, to where I could not lower my arm all the way without discomfort. The passive, shooting pain persisted until day 4. My entire shoulder area from my clavicle to armpit and around the injection site was painful to the touch. The fever continued until day 3. I am now on day 6 and the armpit swelling is mostly gone, but still persistent. The arm pain on movement is gone, most of the pain to the touch is gone, except directly at the injection site where there is still slight swelling.
Patient began to experience headaches on 10/29 about 2 weeks after administration of the second COVID19 vaccine. He was admitted to the hospital. Labs and imaging obtained. Head imaging showed sphenoid sinusitis. MRI/MRA showing suspected left greater than right cavernous sinus thrombosis, likely secondary to sphenoid sinusitis, with associated mild narrowing of the left cavernous internal carotid artery. Patient started on anticoagulation and discharged home on anticoagulation. He also went to the OR on 11/21 for sphenoidotomy and drainage of fluid. Cavernous sinus thrombosis likely secondary to sphenoid sinusitis but because of the timing of second vaccine consulted ID who recommended submitting VAERS form and sending platelet factor 4 antibody- still pending.
I started getting dizzy, chilled and shaky around 1:PM, that continued for several hours then came the headache and stiff limbs, loss of appetite, sour eyes and weakness, I took Tylenol two that evening and two more around 5:AM the next day.
Experienced sore arm and severe migraines for 3 days post 1st vaccination. A week after vaccination, experienced redness and cellulitis at injection site, as well as fever, nystagmus that resulted in hospitalization. Currently on antibiotic treatment.
Swollen from shoulder to elbow- red and warm to touch. Encourage to apply cold compress and follow up with PMD.